Patents by Inventor Elisabeth Sauzeat

Elisabeth Sauzeat has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Vaccine composition with aluminium hydroxide nanoparticles
    Patent number: 9770505
    Abstract: A vaccine composition comprising at least one antigen and one adjuvant, characterized in that the adjuvant comprises sterile-filterable nanoparticles comprising pseudo-boehmite and polyacrylate.
    Type: Grant
    Filed: July 12, 2012
    Date of Patent: September 26, 2017
    Assignee: SANOFI PASTEUR
    Inventors: Yannick Mathieu, Benedicte Lebeau, Valentin Valtchev, Joel Patarin, Marie Garinot, Jean Haensler, Elisabeth Sauzeat
  • Vaccine Composition With Aluminium Hydroxide Nanoparticles
    Publication number: 20140234422
    Abstract: A vaccine composition comprising at least one antigen and one adjuvant, characterized in that the adjuvant comprises sterile-filterable nanoparticles comprising pseudo-boehmite and polyacrylate.
    Type: Application
    Filed: July 12, 2012
    Publication date: August 21, 2014
    Applicant: SANOFI PASTEUR
    Inventors: Yannick Mathieu, Bénédicte Lebeau, Valentin Valtech, Jöel Patarin, Marie Garinot, Jean Haensler, Elisabeth Sauzeat
  • Vaccine composition comprising iron phosphate as vaccine adjuvant
    Patent number: 6927235
    Abstract: The present invention relates to vaccine compositions comprising iron phosphate as adjuvant. This iron phosphate is in the form of particles, the size of which is between 0.01 ?m and 300 ?m; it can be obtained by mixing a solution of iron salt and of phosphate salt.
    Type: Grant
    Filed: May 14, 2004
    Date of Patent: August 9, 2005
    Assignee: Sanofi Pasteur S.A.
    Inventor: Elisabeth Sauzeat
  • Vaccine composition comprising iron phosphate as vaccine adjuvant
    Publication number: 20040228880
    Abstract: The present invention relates to vaccine compositions comprising iron phosphate as adjuvant. This iron phosphate is in the form of particles, the size of which is between 0.01 &mgr;m and 300 &mgr;m; it can be obtained by mixing a solution of iron salt and of phosphate salt.
    Type: Application
    Filed: May 14, 2004
    Publication date: November 18, 2004
    Applicant: Aventis Pasteur SA
    Inventor: Elisabeth Sauzeat